Overview

Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The study tests the hypothesis that systemic and renal nitric oxide availability is changed in polycystic kidney disease and chronic glomerulonephritis.

Phase:

Phase 1

Details

Lead Sponsor:

Regional Hospital Holstebro

Treatments:

omega-N-Methylarginine